NEXGEL to Report Third Quarter 2025 Financial Results on November 11th

Rhea-AI Summary

NEXGEL (NASDAQ:NXGL) will report third quarter 2025 financial results after market close on November 11, 2025. Management will host a conference call the same day at 4:30 P.M. ET to discuss the results and answer questions.

Call details: live dial-in 1-800-579-2543 (U.S. toll free) or 1-785-424-1789 (international); webcast via the company's Events and Presentations page. A replay is available through November 25, 2025 at 1-844-512-2921 (U.S. toll free) or 1-412-317-6671 (international) using code 11160116. An archived webcast will remain available for 90 days.

Management will host a conference call at 4:30 P.M. ET on the same day

LANGHORNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the third quarter 2025, after the market close on November 11, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

Third Quarter 2025 Financial Results Conference Call
Date: November 11, 2025
Time: 4:30 P.M. ET
Live Call: 1-800-579-2543 (U.S. Toll Free) or 1-785-424-1789 (International)
Webcast: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through November 25, 2025, by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11160116. An archived version of the webcast will also be available for 90 days.

About NEXGEL, INC.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com

FAQ

When will NEXGEL (NXGL) release Q3 2025 financial results?

NEXGEL will release its Q3 2025 financial results after market close on November 11, 2025.

What time is the NEXGEL (NXGL) Q3 2025 earnings call on November 11, 2025?

The conference call is scheduled for 4:30 P.M. ET on November 11, 2025.

How can investors join the live NEXGEL (NXGL) Q3 2025 call?

Join live by dialing 1-800-579-2543 (U.S. toll free) or 1-785-424-1789 (international) or via the webcast on the Events and Presentations page.

Will there be a replay of the NEXGEL (NXGL) Q3 2025 conference call?

Yes. A replay is available through November 25, 2025 by dialing 1-844-512-2921 (U.S. toll free) or 1-412-317-6671 (international) using code 11160116.

How long will the NEXGEL (NXGL) webcast be archived after the Q3 2025 call?

The webcast will be archived and available for 90 days following the call.

Where can I find the NEXGEL (NXGL) Q3 2025 webcast and supporting materials?

The live webcast and archived presentation will be posted on NEXGEL's Events and Presentations page on the company's investor website.